Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Fp MDPI and FS MDPI vs Advair Diskus in Pediatric Asthma
NCT02680561Phase 1Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Apr 2016
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of fluticasone propionate and salmeterol in asthma (3 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoints: Maximum observed plasma drug concentration at 4 months and Area under the plasma drug concentration-time curve at 4 months. Started Apr 2016; status: completed.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02680561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02680561.